About this trial
The goal of this observational study is to learn if a hysteroscopy exam alone can find chronic endometritis, a long-lasting inflammation of the lining of the uterus. A hysteroscopy is an exam that looks inside the uterus with a thin camera. Chronic endometritis is usually confirmed with a lab test that counts CD138-positive cells, a type of immune cell, in a small tissue sample from the uterus.
About 100 women will take part. All are already having a hysteroscopy and a tissue sample as part of their fertility care, often after repeated failed embryo transfers or repeated miscarriage.
The main question it aims to answer is:
Do the visual signs seen during hysteroscopy relate closely enough to the CD138 cell count to reliably find chronic endometritis without a lab test?
Participants will:
Have a hysteroscopy exam and a tissue sample from the uterus, both already part of their routine fertility care Have their hysteroscopy video reviewed by two doctors who do not know the tissue sample results Have their tissue sample checked in the lab for CD138 cells
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Woman aged 18-46 years undergoing office hysteroscopy with endometrial biopsy as part of her clinical work-up (including assisted reproduction/PMA pathways), for any indication (recurrent implantation failure, recurrent pregnancy loss, or other).
Examination performed during the early-to-mid proliferative phase (cycle days 6-12) of a spontaneous cycle not exposed to exogenous progestins
Written informed consent to participation and to data processing
Disqualifiers
Current or suspected pregnancy
Postmenopausal status
Clinically active pelvic or lower genital tract infection
Systemic antibiotic use within the preceding 4 weeks
Trial population
Women aged 18-46 years referred for office hysteroscopy with endometrial biopsy at Centro A.M.B.R.A. (Palermo, Italy), for any clinical indication including recurrent implantation failure, recurrent pregnancy loss, or other reasons. All examinations are performed during the early-to-mid proliferative phase (cycle days 6-12) of a spontaneous, non-progestin-exposed menstrual cycle. Approximately 100 participants will be prospectively enrolled and registered; an additional approximately 20 patients evaluated before study initiation constitute a separate pilot cohort and are not included in this population.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Spearman correlation between CD138-positive endometrial plasma cell count and number of positive hysteroscopic signs of chronic endometritis
Correlation (Spearman's rho) between the count of CD138-positive endometrial stromal plasma cells, quantified by immunohistochemistry as a continuous variable, and the number of positive hysteroscopic signs among the six Cicinelli criteria (range 0-6). The primary hypothesis is one of equivalence: the true correlation is hypothesized to fall within a pre-specified smallest effect size of interest (SESOI) of \|r\| \< 0.25. Equivalence is assessed using two one-sided tests (TOST) and complemented by a Bayes Factor quantifying the evidence in favor of the null hypothesis, together with the posterior probability that \|r\| is below the SESOI.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: